Global Diabetes Care Device Market

Diabetes Care Device Comprehensive Study by Type (SMBG, CGMS, Lancet, Insulin Pumps, Insulin Pens), Blood Glucose Monitoring Device (Testing Strips, Self-monitoring Blood Glucose Meters, Lancets, Continuous Glucose Monitors), Insulin Delivery Device (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Others), End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers, Academic & Research Institutes, Home Care, Others) Players and Region - Global Market Outlook to 2030

Diabetes Care Device Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Diabetes Care Device
The diabetes is caused due to an increase in blood sugar level for a long period. This is due to either pancreas not producing enough insulin or cells of the body not responding to the insulin produced. The main goal of diabetes care devices is to minimize the risk of diabetes and to provide continuous monitoring of sugar level. Increasing obese population and government initiatives for providing diabetes cure treatment are the key drivers for the market. Additionally, rising demand for fast, safe and better diabetes care products have been supplementing the growth of the market. However, lack of awareness of diabetes care devices, rising health awareness across the globe and adverse effects associated with diabetes care devices are directly hampering the overall growth of the market. Moreover, rising international research collaboration for diabetes care products and increasing investment in research and development activities lead to new innovation may create a big opportunity for the market in the coming years.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Billion)


The Players having a strong hold in the market are Roche Holding AG, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Ascensia Diabetes. Analyst at AMA Research estimates that United States, European and Asian Players will contribute the maximum growth to Global Diabetes Care Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Roche Holding AG (Switzerland), Medtronic plc (United States), Johnson & Johnson (United States), Abbott Laboratories (United States), Ascensia Diabetes Care Holdings AG (United States), Becton Dickinson (United States), Dexcom (United States), ARKRAY Healthcare Pvt. Ltd. (India), B. Braun Melsungen (Germany) and Terumo Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Ypsomed Holding (Switzerland), Sannuo Biological Sensing Co Ltd (China0, I Sens Inc (South Korea) and Alere Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Diabetes Care Device market by Type (SMBG, CGMS, Lancet, Insulin Pumps and Insulin Pens) and Region.



On the basis of geography, the market of Diabetes Care Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Blood Glucose Monitoring Device, the sub-segment i.e. Testing Strips will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Insulin Delivery Device, the sub-segment i.e. Insulin Syringes will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Diabetes Care Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Population Suffering from Diabetes due to Sedentary Lifestyle

Market Growth Drivers:
Increasing Government Initiatives for Providing Diabetes Cure Treatment, Rising Demand for Fast, Safe and Better Diabetes Care Products and Increasing Obese Population

Challenges:
Adverse effects associated with Diabetes Care Devices

Restraints:
Lack of Awareness of Diabetes Care Devices and Rising Heath Awareness across the Globe

Opportunities:
Rising International Research Collaboration for Diabetes Care Products and Increasing Investment in Research and Development Activities lead to New Innovation

Market Leaders and their expansionary development strategies
In August 2017, pharmaceutical Novo Nordisk had acquired Bristol University spin-out Ziylo in approximately USD 796 million. This acquisition helps the company to develop smart insulin.
In August 2016, Roche Holding AG had launched Accu-Chek Guide blood glucose monitoring system named as Accu-Chek. The new product is design to offers monitoring of glucose on a daily basis along with features such as the spill-resistant SmartPack test strip vial that is used to remove just one strip at a time.


Key Target Audience
Diabetes Care Device Manufacturers, Raw Material Suppliers, Distributors and Suppliers, Government Association, Diabetes Research Organization, Investors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • SMBG
  • CGMS
  • Lancet
  • Insulin Pumps
  • Insulin Pens
By Blood Glucose Monitoring Device
  • Testing Strips
  • Self-monitoring Blood Glucose Meters
  • Lancets
  • Continuous Glucose Monitors

By Insulin Delivery Device
  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • Others

By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Academic & Research Institutes
  • Home Care
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Government Initiatives for Providing Diabetes Cure Treatment
      • 3.2.2. Rising Demand for Fast, Safe and Better Diabetes Care Products
      • 3.2.3. Increasing Obese Population
    • 3.3. Market Challenges
      • 3.3.1. Adverse effects associated with Diabetes Care Devices
    • 3.4. Market Trends
      • 3.4.1. Increasing Population Suffering from Diabetes due to Sedentary Lifestyle
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diabetes Care Device, by Type, Blood Glucose Monitoring Device, Insulin Delivery Device, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Diabetes Care Device (Value)
      • 5.2.1. Global Diabetes Care Device by: Type (Value)
        • 5.2.1.1. SMBG
        • 5.2.1.2. CGMS
        • 5.2.1.3. Lancet
        • 5.2.1.4. Insulin Pumps
        • 5.2.1.5. Insulin Pens
      • 5.2.2. Global Diabetes Care Device by: Blood Glucose Monitoring Device (Value)
        • 5.2.2.1. Testing Strips
        • 5.2.2.2. Self-monitoring Blood Glucose Meters
        • 5.2.2.3. Lancets
        • 5.2.2.4. Continuous Glucose Monitors
      • 5.2.3. Global Diabetes Care Device by: Insulin Delivery Device (Value)
        • 5.2.3.1. Insulin Syringes
        • 5.2.3.2. Insulin Pens
        • 5.2.3.3. Insulin Pumps
        • 5.2.3.4. Insulin Jet Injectors
        • 5.2.3.5. Others
      • 5.2.4. Global Diabetes Care Device by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgery Centers
        • 5.2.4.3. Diagnostic Centers
        • 5.2.4.4. Academic & Research Institutes
        • 5.2.4.5. Home Care
        • 5.2.4.6. Others
      • 5.2.5. Global Diabetes Care Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Diabetes Care Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Holding AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ascensia Diabetes Care Holdings AG (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton Dickinson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dexcom (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ARKRAY Healthcare Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Terumo Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diabetes Care Device Sale, by Type, Blood Glucose Monitoring Device, Insulin Delivery Device, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Diabetes Care Device (Value)
      • 7.2.1. Global Diabetes Care Device by: Type (Value)
        • 7.2.1.1. SMBG
        • 7.2.1.2. CGMS
        • 7.2.1.3. Lancet
        • 7.2.1.4. Insulin Pumps
        • 7.2.1.5. Insulin Pens
      • 7.2.2. Global Diabetes Care Device by: Blood Glucose Monitoring Device (Value)
        • 7.2.2.1. Testing Strips
        • 7.2.2.2. Self-monitoring Blood Glucose Meters
        • 7.2.2.3. Lancets
        • 7.2.2.4. Continuous Glucose Monitors
      • 7.2.3. Global Diabetes Care Device by: Insulin Delivery Device (Value)
        • 7.2.3.1. Insulin Syringes
        • 7.2.3.2. Insulin Pens
        • 7.2.3.3. Insulin Pumps
        • 7.2.3.4. Insulin Jet Injectors
        • 7.2.3.5. Others
      • 7.2.4. Global Diabetes Care Device by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgery Centers
        • 7.2.4.3. Diagnostic Centers
        • 7.2.4.4. Academic & Research Institutes
        • 7.2.4.5. Home Care
        • 7.2.4.6. Others
      • 7.2.5. Global Diabetes Care Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diabetes Care Device: by Type(USD Billion)
  • Table 2. Diabetes Care Device SMBG , by Region USD Billion (2018-2023)
  • Table 3. Diabetes Care Device CGMS , by Region USD Billion (2018-2023)
  • Table 4. Diabetes Care Device Lancet , by Region USD Billion (2018-2023)
  • Table 5. Diabetes Care Device Insulin Pumps , by Region USD Billion (2018-2023)
  • Table 6. Diabetes Care Device Insulin Pens , by Region USD Billion (2018-2023)
  • Table 7. Diabetes Care Device: by Blood Glucose Monitoring Device(USD Billion)
  • Table 8. Diabetes Care Device Testing Strips , by Region USD Billion (2018-2023)
  • Table 9. Diabetes Care Device Self-monitoring Blood Glucose Meters , by Region USD Billion (2018-2023)
  • Table 10. Diabetes Care Device Lancets , by Region USD Billion (2018-2023)
  • Table 11. Diabetes Care Device Continuous Glucose Monitors , by Region USD Billion (2018-2023)
  • Table 12. Diabetes Care Device: by Insulin Delivery Device(USD Billion)
  • Table 13. Diabetes Care Device Insulin Syringes , by Region USD Billion (2018-2023)
  • Table 14. Diabetes Care Device Insulin Pens , by Region USD Billion (2018-2023)
  • Table 15. Diabetes Care Device Insulin Pumps , by Region USD Billion (2018-2023)
  • Table 16. Diabetes Care Device Insulin Jet Injectors , by Region USD Billion (2018-2023)
  • Table 17. Diabetes Care Device Others , by Region USD Billion (2018-2023)
  • Table 18. Diabetes Care Device: by End User(USD Billion)
  • Table 19. Diabetes Care Device Hospitals , by Region USD Billion (2018-2023)
  • Table 20. Diabetes Care Device Ambulatory Surgery Centers , by Region USD Billion (2018-2023)
  • Table 21. Diabetes Care Device Diagnostic Centers , by Region USD Billion (2018-2023)
  • Table 22. Diabetes Care Device Academic & Research Institutes , by Region USD Billion (2018-2023)
  • Table 23. Diabetes Care Device Home Care , by Region USD Billion (2018-2023)
  • Table 24. Diabetes Care Device Others , by Region USD Billion (2018-2023)
  • Table 25. South America Diabetes Care Device, by Country USD Billion (2018-2023)
  • Table 26. South America Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 27. South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 28. South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 29. South America Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 30. Brazil Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 31. Brazil Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 32. Brazil Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 33. Brazil Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 34. Argentina Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 35. Argentina Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 36. Argentina Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 37. Argentina Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 38. Rest of South America Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 39. Rest of South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 40. Rest of South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 41. Rest of South America Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 42. Asia Pacific Diabetes Care Device, by Country USD Billion (2018-2023)
  • Table 43. Asia Pacific Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 44. Asia Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 45. Asia Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 46. Asia Pacific Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 47. China Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 48. China Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 49. China Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 50. China Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 51. Japan Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 52. Japan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 53. Japan Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 54. Japan Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 55. India Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 56. India Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 57. India Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 58. India Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 59. South Korea Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 60. South Korea Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 61. South Korea Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 62. South Korea Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 63. Taiwan Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 64. Taiwan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 65. Taiwan Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 66. Taiwan Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 67. Australia Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 68. Australia Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 69. Australia Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 70. Australia Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 71. Rest of Asia-Pacific Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 72. Rest of Asia-Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 73. Rest of Asia-Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 74. Rest of Asia-Pacific Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 75. Europe Diabetes Care Device, by Country USD Billion (2018-2023)
  • Table 76. Europe Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 77. Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 78. Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 79. Europe Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 80. Germany Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 81. Germany Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 82. Germany Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 83. Germany Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 84. France Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 85. France Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 86. France Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 87. France Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 88. Italy Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 89. Italy Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 90. Italy Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 91. Italy Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 92. United Kingdom Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 93. United Kingdom Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 94. United Kingdom Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 95. United Kingdom Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 96. Netherlands Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 97. Netherlands Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 98. Netherlands Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 99. Netherlands Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 100. Rest of Europe Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 101. Rest of Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 102. Rest of Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 103. Rest of Europe Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 104. MEA Diabetes Care Device, by Country USD Billion (2018-2023)
  • Table 105. MEA Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 106. MEA Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 107. MEA Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 108. MEA Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 109. Middle East Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 110. Middle East Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 111. Middle East Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 112. Middle East Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 113. Africa Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 114. Africa Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 115. Africa Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 116. Africa Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 117. North America Diabetes Care Device, by Country USD Billion (2018-2023)
  • Table 118. North America Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 119. North America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 120. North America Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 121. North America Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 122. United States Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 123. United States Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 124. United States Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 125. United States Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 126. Canada Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 127. Canada Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 128. Canada Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 129. Canada Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 130. Mexico Diabetes Care Device, by Type USD Billion (2018-2023)
  • Table 131. Mexico Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Table 132. Mexico Diabetes Care Device, by Insulin Delivery Device USD Billion (2018-2023)
  • Table 133. Mexico Diabetes Care Device, by End User USD Billion (2018-2023)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Diabetes Care Device: by Type(USD Billion)
  • Table 145. Diabetes Care Device SMBG , by Region USD Billion (2025-2030)
  • Table 146. Diabetes Care Device CGMS , by Region USD Billion (2025-2030)
  • Table 147. Diabetes Care Device Lancet , by Region USD Billion (2025-2030)
  • Table 148. Diabetes Care Device Insulin Pumps , by Region USD Billion (2025-2030)
  • Table 149. Diabetes Care Device Insulin Pens , by Region USD Billion (2025-2030)
  • Table 150. Diabetes Care Device: by Blood Glucose Monitoring Device(USD Billion)
  • Table 151. Diabetes Care Device Testing Strips , by Region USD Billion (2025-2030)
  • Table 152. Diabetes Care Device Self-monitoring Blood Glucose Meters , by Region USD Billion (2025-2030)
  • Table 153. Diabetes Care Device Lancets , by Region USD Billion (2025-2030)
  • Table 154. Diabetes Care Device Continuous Glucose Monitors , by Region USD Billion (2025-2030)
  • Table 155. Diabetes Care Device: by Insulin Delivery Device(USD Billion)
  • Table 156. Diabetes Care Device Insulin Syringes , by Region USD Billion (2025-2030)
  • Table 157. Diabetes Care Device Insulin Pens , by Region USD Billion (2025-2030)
  • Table 158. Diabetes Care Device Insulin Pumps , by Region USD Billion (2025-2030)
  • Table 159. Diabetes Care Device Insulin Jet Injectors , by Region USD Billion (2025-2030)
  • Table 160. Diabetes Care Device Others , by Region USD Billion (2025-2030)
  • Table 161. Diabetes Care Device: by End User(USD Billion)
  • Table 162. Diabetes Care Device Hospitals , by Region USD Billion (2025-2030)
  • Table 163. Diabetes Care Device Ambulatory Surgery Centers , by Region USD Billion (2025-2030)
  • Table 164. Diabetes Care Device Diagnostic Centers , by Region USD Billion (2025-2030)
  • Table 165. Diabetes Care Device Academic & Research Institutes , by Region USD Billion (2025-2030)
  • Table 166. Diabetes Care Device Home Care , by Region USD Billion (2025-2030)
  • Table 167. Diabetes Care Device Others , by Region USD Billion (2025-2030)
  • Table 168. South America Diabetes Care Device, by Country USD Billion (2025-2030)
  • Table 169. South America Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 170. South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 171. South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 172. South America Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 173. Brazil Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 174. Brazil Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 175. Brazil Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 176. Brazil Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 177. Argentina Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 178. Argentina Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 179. Argentina Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 180. Argentina Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 181. Rest of South America Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 182. Rest of South America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 183. Rest of South America Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 184. Rest of South America Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 185. Asia Pacific Diabetes Care Device, by Country USD Billion (2025-2030)
  • Table 186. Asia Pacific Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 187. Asia Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 188. Asia Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 189. Asia Pacific Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 190. China Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 191. China Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 192. China Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 193. China Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 194. Japan Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 195. Japan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 196. Japan Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 197. Japan Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 198. India Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 199. India Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 200. India Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 201. India Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 202. South Korea Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 203. South Korea Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 204. South Korea Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 205. South Korea Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 206. Taiwan Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 207. Taiwan Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 208. Taiwan Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 209. Taiwan Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 210. Australia Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 211. Australia Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 212. Australia Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 213. Australia Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 214. Rest of Asia-Pacific Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 215. Rest of Asia-Pacific Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 216. Rest of Asia-Pacific Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 217. Rest of Asia-Pacific Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 218. Europe Diabetes Care Device, by Country USD Billion (2025-2030)
  • Table 219. Europe Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 220. Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 221. Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 222. Europe Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 223. Germany Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 224. Germany Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 225. Germany Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 226. Germany Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 227. France Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 228. France Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 229. France Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 230. France Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 231. Italy Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 232. Italy Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 233. Italy Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 234. Italy Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 235. United Kingdom Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 236. United Kingdom Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 237. United Kingdom Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 238. United Kingdom Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 239. Netherlands Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 240. Netherlands Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 241. Netherlands Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 242. Netherlands Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 243. Rest of Europe Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 244. Rest of Europe Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 245. Rest of Europe Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 246. Rest of Europe Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 247. MEA Diabetes Care Device, by Country USD Billion (2025-2030)
  • Table 248. MEA Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 249. MEA Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 250. MEA Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 251. MEA Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 252. Middle East Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 253. Middle East Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 254. Middle East Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 255. Middle East Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 256. Africa Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 257. Africa Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 258. Africa Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 259. Africa Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 260. North America Diabetes Care Device, by Country USD Billion (2025-2030)
  • Table 261. North America Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 262. North America Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 263. North America Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 264. North America Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 265. United States Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 266. United States Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 267. United States Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 268. United States Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 269. Canada Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 270. Canada Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 271. Canada Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 272. Canada Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 273. Mexico Diabetes Care Device, by Type USD Billion (2025-2030)
  • Table 274. Mexico Diabetes Care Device, by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Table 275. Mexico Diabetes Care Device, by Insulin Delivery Device USD Billion (2025-2030)
  • Table 276. Mexico Diabetes Care Device, by End User USD Billion (2025-2030)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diabetes Care Device: by Type USD Billion (2018-2023)
  • Figure 5. Global Diabetes Care Device: by Blood Glucose Monitoring Device USD Billion (2018-2023)
  • Figure 6. Global Diabetes Care Device: by Insulin Delivery Device USD Billion (2018-2023)
  • Figure 7. Global Diabetes Care Device: by End User USD Billion (2018-2023)
  • Figure 8. South America Diabetes Care Device Share (%), by Country
  • Figure 9. Asia Pacific Diabetes Care Device Share (%), by Country
  • Figure 10. Europe Diabetes Care Device Share (%), by Country
  • Figure 11. MEA Diabetes Care Device Share (%), by Country
  • Figure 12. North America Diabetes Care Device Share (%), by Country
  • Figure 13. Global Diabetes Care Device share by Players 2023 (%)
  • Figure 14. Global Diabetes Care Device share by Players (Top 3) 2023(%)
  • Figure 15. Global Diabetes Care Device share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche Holding AG (Switzerland) Revenue: by Geography 2023
  • Figure 19. Medtronic plc (United States) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic plc (United States) Revenue: by Geography 2023
  • Figure 21. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 25. Ascensia Diabetes Care Holdings AG (United States) Revenue, Net Income and Gross profit
  • Figure 26. Ascensia Diabetes Care Holdings AG (United States) Revenue: by Geography 2023
  • Figure 27. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton Dickinson (United States) Revenue: by Geography 2023
  • Figure 29. Dexcom (United States) Revenue, Net Income and Gross profit
  • Figure 30. Dexcom (United States) Revenue: by Geography 2023
  • Figure 31. ARKRAY Healthcare Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 32. ARKRAY Healthcare Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 33. B. Braun Melsungen (Germany) Revenue, Net Income and Gross profit
  • Figure 34. B. Braun Melsungen (Germany) Revenue: by Geography 2023
  • Figure 35. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Terumo Corporation (Japan) Revenue: by Geography 2023
  • Figure 37. Global Diabetes Care Device: by Type USD Billion (2025-2030)
  • Figure 38. Global Diabetes Care Device: by Blood Glucose Monitoring Device USD Billion (2025-2030)
  • Figure 39. Global Diabetes Care Device: by Insulin Delivery Device USD Billion (2025-2030)
  • Figure 40. Global Diabetes Care Device: by End User USD Billion (2025-2030)
  • Figure 41. South America Diabetes Care Device Share (%), by Country
  • Figure 42. Asia Pacific Diabetes Care Device Share (%), by Country
  • Figure 43. Europe Diabetes Care Device Share (%), by Country
  • Figure 44. MEA Diabetes Care Device Share (%), by Country
  • Figure 45. North America Diabetes Care Device Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche Holding AG (Switzerland)
  • Medtronic plc (United States)
  • Johnson & Johnson (United States)
  • Abbott Laboratories (United States)
  • Ascensia Diabetes Care Holdings AG (United States)
  • Becton Dickinson (United States)
  • Dexcom (United States)
  • ARKRAY Healthcare Pvt. Ltd. (India)
  • B. Braun Melsungen (Germany)
  • Terumo Corporation (Japan)
Additional players considered in the study are as follows:
Ypsomed Holding (Switzerland) , Sannuo Biological Sensing Co Ltd (China0 , I Sens Inc (South Korea) , Alere Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 240 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Diabetes Care Device Market Quantitative research analysis
Global Diabetes Care Device Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Roche Holding AG (Switzerland), Medtronic plc (United States), Johnson & Johnson (United States), Abbott Laboratories (United States), Ascensia Diabetes Care Holdings AG (United States), Becton Dickinson (United States), Dexcom (United States), ARKRAY Healthcare Pvt. Ltd. (India), B. Braun Melsungen (Germany) and Terumo Corporation (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Population Suffering from Diabetes due to Sedentary Lifestyle" is seen as one of major influencing trends for Diabetes Care Device Market during projected period 2023-2030.
The Diabetes Care Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Diabetes Care Device Market Report?

Have a Query? Click Here

Other Related Reports

Ambulance Equipment Comprehensive Study by Type (Transportation Equipment, Burn Care Equipment, Blood and Hemorrhage Control Equipment, Diagnostic and Infection Control Equipment, Respiratory, Hypoth...
$ 3650
Surgical Drains/Wound Drainage Systems Comprehensive Study by Type (Open Surgical Drainage Systems, Closed Surgical Drainage Systems), Application (General Surgery, Cardiac & Thoracic Surgery, Orthop...
$ 3450
Congestive Heart Failure (CHF) Treatment Devices Comprehensive Study by Type (Ventricular Assist Devices, Counter Pulsation Devices, Implantable Cardioverter Defibrillators, Other), Distribution Chan...
$ 3450
Patient Handling Equipments Comprehensive Study by Type (Patient Transfer Devices, Patient Lifts, Slings, Air-assisted Lateral Transfer Mattresses, Sliding Sheets, Accessories, Medical Beds, Mobility...
$ 3750
Blood Donor Chair Comprehensive Study by Type (Non-adjustable Blood Donor Chair, Electric Blood Donor Chair, Manual Blood Transfusion Chair), Application (Blood center, Hospital, Others), Distributio...
$ 3650
Endoscopic Camera Comprehensive Study by Type (Endoscope, Mechanical Endoscopic Equipment, Visualization & Documentation Systems, Others), Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology...
$ 3650